Duchenne (SGT-003): 23 participants have been dosed in the INSPIRE DUCHENNE trial as of October 31, 2025; Solid expects to ...
Altimmune continues developing pemvidutide for MASH but has yet to secure a partner or acquisition despite sector M&A ...
Background: Individuals with Rett Syndrome (RTT) frequently experience comorbid epilepsy. Few studies have examined the impact of epilepsy healthcare utilization using real-world datasets among RTT.
Recursion Pharmaceuticals trades at a $2.65bn valuation despite slow clinical progress, high cash burn, and no late-stage assets. RXRX's AI-driven drug discovery model is ambitious, but pipeline value ...
NEW YORK, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated to pioneering novel treatments for cardiovascular diseases, ...
– First subject dosed in second Phase 1b clinical study in the European Union assessing the anxiolytic and CNS pharmacological effects of NTX-1955 – – FDA cleared IND for initiation of a U.S. Phase 2 ...
North Carolina head coach Bill Belichick spoke to the media at the Kenan Football Center on Tuesday to discuss the upcoming matchup with Clemson, the quarterback controversy and the offensive line.
The AI medical scribe solutions market has boomed in the past year, saving physicians significant time and enhancing the quality of healthcare interactions for patients. They've proven indispensable ...
Shares of Protagenic Therapeutics Inc (NASDAQ:PTIX) are trading sharply higher Thursday afternoon, soaring over 100% midday after the company announced a key clinical milestone. What To Know: This ...
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) is one of the 11 Best Short-Term Stocks to Invest in. The company sees its Buy rating reiterated following promising results from its clinical trials, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback